Charles River Laboratories Total Assets 2010-2024 | CRL

Charles River Laboratories total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Charles River Laboratories total assets for the quarter ending September 30, 2024 were $8.004B, a 5.22% increase year-over-year.
  • Charles River Laboratories total assets for 2023 were $8.195B, a 7.79% increase from 2022.
  • Charles River Laboratories total assets for 2022 were $7.603B, a 8.24% increase from 2021.
  • Charles River Laboratories total assets for 2021 were $7.024B, a 27.93% increase from 2020.
Charles River Laboratories Annual Total Assets
(Millions of US $)
2023 $8,195
2022 $7,603
2021 $7,024
2020 $5,491
2019 $4,693
2018 $3,856
2017 $2,930
2016 $2,712
2015 $2,068
2014 $1,871
2013 $1,633
2012 $1,586
2011 $1,558
2010 $1,733
2009 $2,204
Charles River Laboratories Quarterly Total Assets
(Millions of US $)
2024-09-30 $8,004
2024-06-30 $7,948
2024-03-31 $8,153
2023-12-31 $8,195
2023-09-30 $7,607
2023-06-30 $7,772
2023-03-31 $7,699
2022-12-31 $7,603
2022-09-30 $7,383
2022-06-30 $7,529
2022-03-31 $7,075
2021-12-31 $7,024
2021-09-30 $7,058
2021-06-30 $6,720
2021-03-31 $5,809
2020-12-31 $5,491
2020-09-30 $5,213
2020-06-30 $5,241
2020-03-31 $5,202
2019-12-31 $4,693
2019-09-30 $4,583
2019-06-30 $4,625
2019-03-31 $3,927
2018-12-31 $3,856
2018-09-30 $3,797
2018-06-30 $3,866
2018-03-31 $3,001
2017-12-31 $2,930
2017-09-30 $2,866
2017-06-30 $2,774
2017-03-31 $2,697
2016-12-31 $2,712
2016-09-30 $2,690
2016-06-30 $2,763
2016-03-31 $2,104
2015-12-31 $2,068
2015-09-30 $2,033
2015-06-30 $1,886
2015-03-31 $1,847
2014-12-31 $1,871
2014-09-30 $1,842
2014-06-30 $1,863
2014-03-31 $1,652
2013-12-31 $1,633
2013-09-30 $1,644
2013-06-30 $1,622
2013-03-31 $1,604
2012-12-31 $1,586
2012-09-30 $1,568
2012-06-30 $1,546
2012-03-31 $1,555
2011-12-31 $1,558
2011-09-30 $1,585
2011-06-30 $1,705
2011-03-31 $1,745
2010-12-31 $1,733
2010-09-30 $2,080
2010-06-30 $2,157
2010-03-31 $2,187
2009-12-31 $2,204
2009-09-30 $2,192
2009-06-30 $2,154
2009-03-31 $2,088
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00